IL-2 dose regulates TNF-α mRNA transcription and protein secretion in human peripheral blood lymphocytes
- 31 January 1991
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 132 (1), 193-200
- https://doi.org/10.1016/0008-8749(91)90018-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages.The Journal of Experimental Medicine, 1990
- Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses.The Journal of cell biology, 1988
- Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody.The Journal of Experimental Medicine, 1988
- Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.The Journal of Experimental Medicine, 1987
- Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression.Journal of Clinical Investigation, 1986
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.The Journal of Experimental Medicine, 1986
- Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.The Journal of Experimental Medicine, 1986
- Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factorsNature, 1986
- Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.The Journal of Experimental Medicine, 1985
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982